Protection For NDIs Bigger Concern In US Than Giving More Time For Notifications, CRN Contends

CRN CEO Steve Mister presents during the Food and Drug Law Institute's annual conference in Washington. • Source: Hannah Daniel/HBW Insight

More from Regulation

More from Policy & Regulation